Literature DB >> 32034694

Serum Uric Acid Levels and Risk of Intracranial Atherosclerotic Stenosis: A Cross-Sectional Study.

Lin Li1, Jun-Xia Zhu2, Xiao-He Hou1, Ya-Hui Ma1, Wei Xu1, Chen-Chen Tan1, Fu-Rong Sun1, Hong-Qi Li3, Qiang Dong4, Lan Tan5, Jin-Tai Yu6.   

Abstract

Elevated serum uric acid (SUA) has been reported to be associated with an increased risk of cardiovascular diseases, but the role of SUA in intracranial atherosclerosis remains unclear. To investigate the association between SUA and intracranial atherosclerotic stenosis (ICAS), we evaluated 1522 subjects (305 with ICAS, 1217 without ICAS) with magnetic resonance angiography (MRA). Subjects were classified into ten groups according to the deciles of the SUA level. The rate of ICAS reached a minimum in the seventh decile (6.0-6.3 mg/dL; reference group). After adjusting for confounding factors, multivariate logistic regression analysis demonstrated that both low SUA level (≤ 3.8 mg/dL; OR, 2.34; 95% CI, 1.29-4.39; p = 0.006) and high SUA level (≥ 7.8 mg/dL; OR, 2.10; 95% CI, 1.15-3.92; p = 0.017) conferred greater risk for ICAS. In multivariable analysis with a quadratic model which used SUA as a continuous variable, a U-shaped association between SUA and the rate of ICAS was confirmed (α > 0; p < 0.001). The estimated SUA level associated with the lowest rate of ICAS was 6.2 mg/dL. In conclusion, our findings suggest a U-shaped association between ICAS and SUA.

Entities:  

Keywords:  Intracranial atherosclerotic stenosis; Magnetic resonance angiography; Serum uric acid; U-shaped association

Mesh:

Substances:

Year:  2020        PMID: 32034694     DOI: 10.1007/s12640-020-00171-7

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  42 in total

Review 1.  Atherosclerosis: current pathogenesis and therapeutic options.

Authors:  Christian Weber; Heidi Noels
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

2.  Release of platelet constituents by monosodium urate crystals.

Authors:  M H Ginsberg; F Kozin; M O'Malley; D J McCarty
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

3.  J-shaped mortality relationship for uric acid in CKD.

Authors:  Mohamed E Suliman; Richard J Johnson; Elvia García-López; A Rashid Qureshi; Hadi Molinaei; Juan Jesús Carrero; Olof Heimbürger; Peter Bárány; Jonas Axelsson; Bengt Lindholm; Peter Stenvinkel
Journal:  Am J Kidney Dis       Date:  2006-11       Impact factor: 8.860

4.  Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study.

Authors:  Vasilios G Athyros; Dimitri P Mikhailidis; Evangelos N Liberopoulos; Anna I Kakafika; Asterios Karagiannis; Athanasios A Papageorgiou; Konstantinos Tziomalos; Emmanuel S Ganotakis; Moses Elisaf
Journal:  Nephrol Dial Transplant       Date:  2006-09-23       Impact factor: 5.992

5.  Japanese guideline for the management of hyperuricemia and gout: second edition.

Authors:  Hisashi Yamanaka
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2011-12       Impact factor: 1.381

6.  Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study.

Authors:  P Verdecchia; G Schillaci; G Reboldi; F Santeusanio; C Porcellati; P Brunetti
Journal:  Hypertension       Date:  2000-12       Impact factor: 10.190

7.  Carotid plaque and intima-media thickness assessed by b-mode ultrasonography in subjects ranging from young adults to centenarians.

Authors:  S Homma; N Hirose; H Ishida; T Ishii; G Araki
Journal:  Stroke       Date:  2001-04       Impact factor: 7.914

8.  Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study.

Authors:  Vasilios G Athyros; Moses Elisaf; Athanasios A Papageorgiou; Athanasios N Symeonidis; Anthimos N Pehlivanidis; Vasilios I Bouloukos; Haralambos J Milionis; Dimitri P Mikhailidis
Journal:  Am J Kidney Dis       Date:  2004-04       Impact factor: 8.860

9.  The Association between Serum Uric Acid Levels and the Prevalence of Vulnerable Atherosclerotic Carotid Plaque: A Cross-sectional Study.

Authors:  Qing Li; Yong Zhou; Kehui Dong; Anxin Wang; Xin Yang; Caifeng Zhang; Yi Zhu; Shouling Wu; Xingquan Zhao
Journal:  Sci Rep       Date:  2015-05-11       Impact factor: 4.379

10.  Diagnosis and treatment for hyperuricaemia and gout: a protocol for a systematic review of clinical practice guidelines and consensus statements.

Authors:  Qianrui Li; Xiaodan Li; Joey Sum-Wing Kwong; Hao Chen; Xin Sun; Haoming Tian; Sheyu Li
Journal:  BMJ Open       Date:  2017-06-23       Impact factor: 2.692

View more
  1 in total

1.  Association Between Serum Uric Acid and Intracranial Arterial Stenosis in a Korean Population: A Secondary Analysis Based on a Cross-Sectional Study.

Authors:  Taotao Yao; Anqi Di; Jialing Li; Shuchen Zhang; Jun He; Nuo Xu; Danghan Xu
Journal:  Front Neurol       Date:  2022-03-11       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.